...
首页> 外文期刊>American Journal of Pathology >Functional and Ultrastructural Analysis of Annexin A1 and Its Receptor in Extravasating Neutrophils during Acute Inflammation
【24h】

Functional and Ultrastructural Analysis of Annexin A1 and Its Receptor in Extravasating Neutrophils during Acute Inflammation

机译:急性炎症过程中渗出的中性粒细胞膜联蛋白A1及其受体的功能和超微结构分析

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this study was twofold: to reveal cellular events associated with the protective role of endogenous annexin A1 (AnxA1) in inflammation and to highlight the potential involvement of members of the formyl peptide receptor (Fpr) family in this process. We found that wild-type, AnxA1-null, and Fpr1-null mice all displayed an intense neutrophil recruitment into the peritoneal cavity as assessed 4 hours after carrageenin injection, and that this recruitment was most pronounced in AnxA1-null mice. In addition, this cell influx could be inhibited by the AnxA1 pharmacophore peptide, Ac2-26, in wild-type, AnxA1-null, and Fpr1-null mice, but was restored when co-treated with the pan-receptor antagonist Boc2. Using the LacZ gene reporter assay, an enhancement of AnxA1 gene promoter activity in extravasated neutrophils was evident in AnxA1-null mice; again this response was reduced after peptide treatment. The lack of functional involvement of Fpr1 prompted us to monitor the structurally related receptor Fpr2. We report, for the first time, the ultrastructural immunocytochemical co-localization of Fpr2 with AnxA1 in neutrophils that migrate into the mesenteric microcirculation and extravasate into the peritoneal fluid. Collectively, these data provide in vivo support to the hypothesis that endogenous AnxA1 is an essential effector of endogenous anti-inflammation and provide an ultrastructural indication that this mediator interacts with Fpr2 in murine neutrophils. We believe that these findings could significantly affect the development of novel therapeutics, which are modeled after the anti-migratory actions of AnxA1.
机译:这项研究的目的是双重的:揭示与内源性膜联蛋白A1 (AnxA1)在炎症中的保护作用有关的细胞事件,并强调可能的参与 < / sup>此 过程中的甲酰肽受体(Fpr)家族成员。我们发现野生型,AnxA1-null和Fpr1-null 小鼠均在角叉菜胶注射后4小时评估显示强烈的嗜中性白细胞募集进入 腹膜腔。 > ,并且该募集在AnxA1-null 小鼠中最为明显。此外, AnxA1药效团肽Ac2-26在野生型AnxA1-null, 和Fpr1-null小鼠中均可以抑制这种细胞的流入,但是当与 pan受体拮抗剂Boc2共同治疗时恢复。使用LacZ基因报告基因检测,在未感染AnxA1的小鼠中, 中性粒细胞中AnxA1基因启动子的活性明显增强。肽处理后,这种反应 再次降低。 Fpr1缺乏功能性参与促使我们监测与结构相关的受体Fpr2。我们首次报告Fpr2和AnxA1在超嗜中性粒细胞中的超微结构免疫细胞化学共定位,该嗜中性粒细胞迁移到肠系膜微循环并渗入肠中膜。腹膜液。总体而言,这些数据为内源性AnxA1是内源性抗炎的一种基本效应子的假设提供了体内支持,并提供了以下超微结构指示:该介体与鼠中性粒细胞中的 Fpr2相互作用。我们认为,这些发现可能会 大大影响新型疗法的发展, 是以AnxA1的抗迁移作用为模型的。

著录项

  • 来源
    《American Journal of Pathology》 |2009年第1期|177-183|共7页
  • 作者单位

    From the Post-Graduation in Morphology,Federal University of S?o Paulo (UNIFESP), Paulista School of Medicine (EPM), S?o Paulo, Brazil;

    the Department of Biology,Instituto de Biociências, Letras e Ciências Exatas, S?o Paulo State University (UNESP), S?o Paulo, Brazil;

    and The William Harvey Research Institute,Barts and The London Medical School, Queen Mary University of London, London, United Kingdom;

    and The William Harvey Research Institute,Barts and The London Medical School, Queen Mary University of London, London, United Kingdom;

    and The William Harvey Research Institute,Barts and The London Medical School, Queen Mary University of London, London, United Kingdom;

    From the Post-Graduation in Morphology,Federal University of S?o Paulo (UNIFESP), Paulista School of Medicine (EPM), S?o Paulo, Brazil|the Department of Biology,Instituto de Biociências, Letras e Ciências Exatas, S?o Paulo State University (UNESP), S?o Paulo, Brazil;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号